For many it’s not funny, given the political heat around language choices

AI forces a return to “natural philosophy,” just as science once needed to leave it

In a recent lecture Chris Whitty, England’s chief medical officer, talked about how setbacks driven by misinformation can be temporary and how evidence and data can rebuild confidence. He was speaking...

La prise en charge globale en oncologie revêt des enjeux particuliers lorsque le cancer frappe un enfant. Au-delà des soins et des soins de support, l’accompagnement entend aider les enfants ainsi que...

Nobel prize winner shaped medicine, crimefighting and genealogy but later years marred by racist remarks James D Watson, whose co-discovery of the twisted-ladder structure of DNA in 1953 helped light the long fuse on a revolution in medicine, crimefighting, genealogy and ethics, has died, according to his former research lab. He was 97. The breakthrough – made when the brash, Chicago-born Watson was just 24 – turned him into a hallowed figure in the world of science for decades. But near the end of his life, he faced condemnation and professional censure for offensive remarks, including saying Black people were less intelligent than white people. Continue reading...

If language is what makes us human, what does it mean now that large language models have gained “metalinguistic” abilities?

After a man lives nearly nine months with a pig kidney, two American firms are preparing clinical trials

The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from the country, blaming insufficient government investment. Central to the dis...

Will the labs devour the apps that run on their models?

Redefining Precision Medicine

The industry has fostered a cult of personality that seems to leave the tech press starstruck and unquestioning of nonsensical claims

The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from the country, blaming insufficient government investment. Central to the dis...

They are pushing tools to the edge, scaling up and relying on fuzzy maths

From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over th | ...

Findings from latest research reflect emerging opportunities in oncology to refine treatments by challenging current paradigms of care

Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.

The ELCAP statements, developed by a group of international experts, help oncology stakeholders recognise the opportunities and the risks of these artificial intelligence systems by categorising them ...

After decades of missed promises, cancer vaccines are likely approaching prime time due to major advances in cancer immunobiology, immunotherapy and biomedical technology

“I’d rather discuss addiction with Dax Shephard on ‘Armchair Expert’ than present at a national meeting if given the option,” writes Jonathan Avery.

The Galleri test looks for fragments of DNA that have broken off a tumour and are circulating in the blood.